Transcode Therapeutics Inc (RNAZ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 5,811 | 2,768 | 4,968 | 20,826 | 828 |
| Receivables | N/A | N/A | 360 | 0 | N/A |
| TOTAL | $7,093 | $4,455 | $7,379 | $22,732 | $831 |
| Non-Current Assets | |||||
| PPE Net | 52 | 121 | 209 | 206 | N/A |
| Investments And Advances | 112 | 112 | 0 | 0 | 0 |
| Other Non-Current Assets | 38 | 482 | 0 | 0 | 224 |
| TOTAL | $201 | $714 | $209 | $206 | $224 |
| Total Assets | $7,295 | $5,170 | $7,588 | $22,938 | $1,055 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,708 | 3,051 | 4,347 | 2,504 | 405 |
| TOTAL | $2,772 | $3,491 | $4,347 | $2,534 | $405 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 25 | 27 | N/A | 31 | N/A |
| Other Non-Current Liabilities | 6,541 | 38 | 0 | 0 | 4,059 |
| TOTAL | $6,541 | $38 | $N/A | $N/A | $4,059 |
| Total Liabilities | $9,313 | $3,529 | $4,347 | $2,534 | $4,464 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 833 | 6 | 15,824 | 12,905 | N/A |
| Common Shares | 0 | 0 | 0 | 1 | 1 |
| Retained earnings | -63,202 | -46,416 | -27,870 | -10,305 | -3,462 |
| Other shareholders' equity | 0 | 0 | 0 | 0 | -13 |
| TOTAL | $-2,019 | $1,641 | $3,241 | $20,404 | $-3,408 |
| Total Liabilities And Equity | $7,295 | $5,170 | $7,588 | $22,939 | $1,055 |